Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.43 | 4e-39 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-17 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.4 | 3e-15 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-15 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.35 | 1e-11 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.34 | 5e-10 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |